KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organon (OGN) EBT (2020 - 2025)

Historic EBT for Organon (OGN) over the last 6 years, with Q3 2025 value amounting to $243.0 million.

  • Organon's EBT rose 1739.13% to $243.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year decrease of 1160.18%. This contributed to the annual value of $1.3 billion for FY2024, which is 480.85% up from last year.
  • As of Q3 2025, Organon's EBT stood at $243.0 million, which was up 1739.13% from $229.0 million recorded in Q2 2025.
  • Organon's EBT's 5-year high stood at $658.0 million during Q4 2023, with a 5-year trough of $80.0 million in Q3 2023.
  • Its 5-year average for EBT is $325.7 million, with a median of $254.0 million in 2023.
  • As far as peak fluctuations go, Organon's EBT plummeted by 7163.12% in 2023, and later surged by 15875.0% in 2024.
  • Organon's EBT (Quarter) stood at $236.0 million in 2021, then surged by 138.14% to $562.0 million in 2022, then increased by 17.08% to $658.0 million in 2023, then fell by 7.6% to $608.0 million in 2024, then plummeted by 60.03% to $243.0 million in 2025.
  • Its EBT stands at $243.0 million for Q3 2025, versus $229.0 million for Q2 2025 and $101.0 million for Q1 2025.